Corcept Therapeutics Inc. Stock
Corcept Therapeutics Inc. shows a slight decrease today, losing -€0.200 (-0.880%) compared to yesterday.
Corcept Therapeutics Inc. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 35 € shows a very positive potential of 54.87% compared to the current price of 22.6 € for Corcept Therapeutics Inc..
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | -0.880% | 6.942% | -2.062% | 3.636% | -24.000% | 25.967% | - |
| Gritstone Oncology Inc | 13.680% | 16.156% | -0.447% | -60.985% | -52.018% | -87.408% | - |
| Avid Bioservices Inc | 6.250% | 11.679% | 31.897% | -54.192% | 25.410% | -53.636% | 89.310% |
| Pacira Pharmaceuticals | - | 4.167% | -3.101% | -34.211% | -16.107% | -50.495% | -41.038% |
Comments
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at HC Wainwright from $38.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $42.00 to $44.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat